11.BETA.,13-DIHYDRO-13-(DIMETHYLAMINO)MICHELIOLIDE

Name: 11.BETA.,13-DIHYDRO-13-(DIMETHYLAMINO)MICHELIOLIDE in Recurrent Glioblastoma
Creator: Floatz
License: https://terminal.floatz.ai/terms

Recurrent Glioblastoma

National Neuroscience InstituteSmall moleculePhase 2Active

58/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 45/ 100
Competitive Position: 81/ 100

Competitive context

353 Active assets in the Recurrent Glioblastoma cohort.

Asset / Sponsor	Phase	Rating
Irinotecan Beijing Sanbo Brain Hospital	Phase 2/3	BBB
Depatuxizumab Mafodotin AbbVie	Phase 3	BB
CARMUSTINE Leland Metheny	Phase 3	BB
Cintredekin Besudotox INSYS Therapeutics Inc	Phase 3	BB
(+)-VINCRISTINE University of Cincinnati	Phase 3	BB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →